Michael A. Metzger, President and COO at Syndax Pharmaceuticals Inc (SNDX), sold 71,173 shares at $19.05 ($1.4M) on 2021-12-13, disclosed to the SEC on 2021-12-15.
Open-market sale of $1.4M SNDX by President and COO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.05 | 2,045 | $39K | 2.9% |
| 2 | $19.05 | 34,564 | $658K | 48.6% |
| 3 | $19.05 | 34,564 | $658K | 48.6% |
| Total | $19.05 avg | 71,173 | $1.4M | 100% |
| Filing → |
| SNDX | SELL | 2026-02-10 | $361K | — | Filing → |
| SNDX | SELL | 2026-02-06 | $153K | — | Filing → |
| SNDX | SELL | 2025-09-08 | $5.2M | — | Filing → |